Published in Rev Infect Dis on December 02, 1982
An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc Natl Acad Sci U S A (2006) 2.34
Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts. Evol Appl (2008) 1.13
Impact of schistosome infection on Plasmodium falciparum Malariometric indices and immune correlates in school age children in Burma Valley, Zimbabwe. PLoS Negl Trop Dis (2010) 1.02
Disability weight of Clonorchis sinensis infection: captured from community study and model simulation. PLoS Negl Trop Dis (2011) 0.95
The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment. BMC Infect Dis (2010) 0.94
Polyparasitism is associated with increased disease severity in Toxoplasma gondii-infected marine sentinel species. PLoS Negl Trop Dis (2011) 0.94
Developmental plasticity in schistosomes and other helminths. Int J Parasitol (2003) 0.92
Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda. PLoS Negl Trop Dis (2012) 0.90
Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. Exp Parasitol (2009) 0.89
Complex links between natural tuberculosis and porcine circovirus type 2 infection in wild boar. Biomed Res Int (2014) 0.82
Schistosoma mansoni: sex-specific modulation of parasite growth by host immune signals. Exp Parasitol (2004) 0.81
Schistosoma mansoni infection impairs antimalaria treatment and immune responses of rhesus macaques infected with mosquito-borne Plasmodium coatneyi. Infect Immun (2012) 0.76
Webuye Health and Demographic Surveillance Systems Baseline Survey of Soil-Transmitted Helminths and Intestinal Protozoa among Children up to Five Years. J Trop Med (2013) 0.76
Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells. Infect Immun (1990) 4.72
Classification of enterotoxins on the basis of activity in cell culture. J Infect Dis (1975) 4.52
Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis (2000) 4.24
The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. J Clin Invest (1972) 4.05
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med (1986) 3.61
Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. J Infect Dis (1989) 3.34
Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc Natl Acad Sci U S A (1987) 3.25
The intolerable burden of malaria: a new look at the numbers. Am J Trop Med Hyg (2001) 3.03
Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol (1992) 3.03
Infection and diabetes: the case for glucose control. Am J Med (1982) 2.90
The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum. J Infect Dis (1972) 2.87
A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli. FEMS Microbiol Lett (1990) 2.76
The susceptibility of bacteroides to the penicillins and cephalothin. Am J Med Sci (1966) 2.52
Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae. J Infect Dis (1972) 2.40
Pathogenesis of Shigella diarrhea. 3. Effects of shigella enterotoxin in cell culture. Trans N Y Acad Sci (1973) 2.26
In vivo transduction with shiga toxin 1-encoding phage. Infect Immun (1998) 2.16
Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun (1996) 2.13
Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect Immun (1989) 2.12
Pathogenesis of Shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving beta1 leads to 4-linked N-acetyl-D-glucosamine oligomers. J Exp Med (1977) 1.97
Shigella toxin(s): description and role in diarrhea and dysentery. Pharmacol Ther (1981) 1.94
The pathogenesis of Shigella diarrhea. VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans. J Infect Dis (1977) 1.92
A review of human immunodeficiency virus infection in India. J Acquir Immune Defic Syndr (1994) 1.88
Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice. Infect Immun (1972) 1.85
A vaccine against rotavirus--when is too much too much? N Engl J Med (1997) 1.82
Summary of a workshop on clindamycin colitis. J Infect Dis (1976) 1.78
Pathogenesis of bacterial diarrheas. I. N Engl J Med (1971) 1.71
Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect Immun (1999) 1.66
Complete amino acid sequence of Shigella toxin B-chain. A novel polypeptide containing 69 amino acids and one disulfide bridge. J Biol Chem (1986) 1.63
Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infect Immun (1994) 1.61
Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock. Infect Immun (1983) 1.58
Enzyme-linked immunosorbent assay for shigella toxin. J Clin Microbiol (1986) 1.57
Production and characterization of exotoxin(s) of Shigella dysenteriae type 1. J Infect Dis (1975) 1.56
Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infectious due to Streptococcus bovis. N Engl J Med (1973) 1.53
Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med (1978) 1.46
Trimethoprim-sulfamethoxazole in the United States. Ann Intern Med (1979) 1.45
Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes. J Clin Microbiol (1993) 1.43
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J Clin Invest (1976) 1.43
Epidemiology of HIV and AIDS in India. AIDS (1994) 1.43
Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect Immun (1996) 1.39
Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine. J Infect Dis (1988) 1.38
The pathogenesis of Shigella diarrhea. V. Relationship of shiga enterotoxin, neurotoxin, and cytotoxin. J Infect Dis (1975) 1.37
Comparison of secretory and histological effects of shigella and cholera enterotoxins in rabbit jejunum. Gastroenterology (1975) 1.35
Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect Immun (2000) 1.34
Mammalian bile promotes growth of Giardia lamblia in axenic culture. Trans R Soc Trop Med Hyg (1983) 1.33
Effect of Shigella enterotoxin on electrolyte transport in rabbit ileum. Gastroenterology (1975) 1.31
Lectin activation in Giardia lamblia by host protease: a novel host-parasite interaction. Science (1986) 1.31
Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J Infect Dis (1989) 1.30
Description and characterization of a surface lectin from Giardia lamblia. Infect Immun (1986) 1.28
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Endocarditis caused by Lactobacillus plantarum. Ann Intern Med (1973) 1.25
Identification and characterization of taglin, a mannose 6-phosphate binding, trypsin-activated lectin from Giardia lamblia. Biochemistry (1987) 1.24
Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. Infect Immun (1996) 1.23
Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infect Immun (1994) 1.21
Enzyme-linked immunosorbent assay for Shiga toxin and Shiga-like toxin II using P1 glycoprotein from hydatid cysts. J Infect Dis (1990) 1.20
Identification of chitin as a structural component of Giardia cysts. Infect Immun (1985) 1.18
One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. Microb Pathog (1993) 1.18
Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun (1999) 1.18
Serum enterotoxin-neutralizing antibody in human shigellosis. Nat New Biol (1973) 1.17
Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J Infect Dis (1994) 1.17
In vitro encystation of Giardia lamblia: large-scale production of in vitro cysts and strain and clone differences in encystation efficiency. J Parasitol (1991) 1.16
Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J Clin Invest (1995) 1.15
Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med (1996) 1.13
Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin. J Infect Dis (1983) 1.13
Pathogenesis of bacterial diarrheas (second of two parts). N Engl J Med (1971) 1.13
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. Drugs (1982) 1.12
Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin. Mol Microbiol (1989) 1.11
Effects of bile and bile salts on growth and membrane lipid uptake by Giardia lamblia. Possible implications for pathogenesis of intestinal disease. J Clin Invest (1985) 1.10
Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems. Infect Immun (1993) 1.09
Shiga toxin: production and purification. Methods Enzymol (1988) 1.09
Shigella toxin and the pathogenesis of shigellosis. Ciba Found Symp (1985) 1.09
Pathogenesis of shigella diarrhea: evidence for an N-linked glycoprotein shigella toxin receptor and receptor modulation by beta-galactosidase. J Infect Dis (1986) 1.09
An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. J Infect Dis (1997) 1.08
Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. Infect Immun (1998) 1.07
Giardia lamblia: evaluation of roller bottle cultivation. Exp Parasitol (1982) 1.07
Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin. Infect Immun (1986) 1.06
Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. J Clin Invest (1989) 1.06
14 C-glucose oxidation in whole blood: a clinical assay for phagocyte dysfunction. Infect Immun (1972) 1.05
Axonally transported Shigella cytotoxin is neuronotoxic. J Neuropathol Exp Neurol (1985) 1.04
Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro. Antimicrob Agents Chemother (1975) 1.03
Identification and partial purification of a lectin on the surface of the sporozoite of Cryptosporidium parvum. J Parasitol (1992) 1.03
Ecological control of the bacterial diarrheas: a scientific strategy. Am J Clin Nutr (1978) 1.02
Biology of Giardia lamblia. Detection of N-acetyl-D-glucosamine as the only surface saccharide moiety and identification of two distinct subsets of trophozoites by lectin binding. J Exp Med (1988) 1.02
Shiga toxin: purification, structure, and function. Rev Infect Dis (1991) 1.01
Primary amines and chloroquine inhibit cytotoxic responses to Shigella toxin and permit late antibody rescue of toxin treated cells. Biochem Biophys Res Commun (1984) 1.00
Intracellular bactericidal activity of leukocytes in whole blood for the diagnosis of chronic granulomatous disease of childhood. J Infect Dis (1975) 1.00
Letter: Staphylococcus aureus antigen in cerebrospinal fluid cross-reactive with Haemophilus influenzae type b antiserum. Ann Intern Med (1975) 0.99
Shigella infections. Clin Gastroenterol (1979) 0.98
Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun (1999) 0.98
HeLa cell adherence and cytotoxin production by enteropathogenic Escherichia coli isolated from infants with diarrhea in Thailand. J Clin Microbiol (1987) 0.98
Lactase deficiency in Thailand: effect of prolonged lactose feeding. Am J Clin Nutr (1969) 0.98
Specific membrane receptors: pathogenetic and therapeutic implications in infectious diseases. Rev Infect Dis (1980) 0.96
Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient. Chest (1976) 0.95
Identification of developmentally regulated Giardia lamblia cyst antigens using GCSA-1, a cyst-specific monoclonal antibody. Mol Microbiol (1990) 0.95
Biochemical effects of cholera enterotoxin: oxidative metabolism in the infant rabbit. Am J Physiol (1970) 0.95
Nutrition and infection. Annu Rev Nutr (1986) 0.94
An 88,000-Mr Giardia lamblia surface protein which is immunogenic in humans. Infect Immun (1986) 0.94
Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. J Eukaryot Microbiol (1995) 0.93
Selective primary health care: strategies for control of disease in the developing world. XXIII. Control of infection to reduce the prevalence of infantile and childhood malnutrition. Rev Infect Dis (1986) 0.93
Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J Leukoc Biol (1992) 0.93